Showing 1 - 10 of 35,207
The theoretical discussion concerning the question whether the incumbent or the (potential) entrant invests more into R&D has attracted considerable interest. This paper reports the results of an empirical study on this question using data of about 3500 German firms over the years 1992 to 1995....
Persistent link: https://www.econbiz.de/10011444512
Do firms increase product lines to deter entry and, if so, when is such a strategy successful? We use data from UK pharmaceuticals to examine how incumbents respond to change in the threat of entry. In line with the entry deterrence motive, originators' product launch rate is higher when the...
Persistent link: https://www.econbiz.de/10012285099
Persistent link: https://www.econbiz.de/10003385480
Barriers to entry are regarded as major impediments to the working of markets. Entry must not necessarily actually take place - the perceived threat of entry may encourage incumbent firms to behave as if they are in a competitive market, even if they are not. We present empirical evidence on...
Persistent link: https://www.econbiz.de/10003751792
Persistent link: https://www.econbiz.de/10012296192
interpretation of theory relating price to competition in generic drug markets. We find significant biases associated with estimates …
Persistent link: https://www.econbiz.de/10014158688
Persistent link: https://www.econbiz.de/10011986639
Persistent link: https://www.econbiz.de/10003378879
Persistent link: https://www.econbiz.de/10012054582
We develop a simple agent-based financial market model in which speculators' market entry decisions are subject to herding behavior and market risk. Moreover, speculators' orders depend on price trends, market misalignments and fundamental news. Using a mix of analytical and numerical tools, we...
Persistent link: https://www.econbiz.de/10011702006